Showing results (191-200 of 216) with videos related to
Sort By:
Pageof 22
Bioorganic & Medicinal Chemistry Letters|August 11, 2000
Solid-phase synthesis of an arylsulfone hydroxamate libraryJ M Salvino, R Mathew, T Kiesow, et al.Studies in Mycology|February 1, 2024
: taxonomic and phylogenetic revision of the genusZ G Abad, T I Burgess, T Bourret, et al.JCI Insight|November 29, 2022
Longitudinal single-cell analysis of SARS-CoV-2-reactive B cells uncovers persistence of early-formed, antigen-specific clonesLydia Scharf, Hannes Axelsson, Aikaterini Emmanouilidi, et al.QJM : Monthly Journal of the Association of Physicians|July 13, 2021
COVID-19-associated mucormycosis presenting to the Emergency Department-an observational study of 70 patientsA Ramaswami, A K Sahu, A Kumar, et al.South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|October 11, 2022
Prophylaxis is the new standard of care in patients with haemophiliaJ Mahlangu, F Bassa, M Bassingthwaighte, et al.Blood|April 9, 2014
Activity of therapeutic JAK 1/2 blockade in graft-versus-host diseaseSilvia Spoerl, Nimitha R Mathew, Michael Bscheider, et al.Rheumatology (Oxford, England)|November 23, 2007
Sjögren's Systemic Clinical Activity Index (SCAI)--a systemic disease activity measure for use in clinical trials in primary Sjögren's syndromeS J Bowman, N Sutcliffe, D A Isenberg, et al.Rheumatology (Oxford, England)|June 6, 2008
The Sjögren's Syndrome Damage Index--a damage index for use in clinical trials and observational studies in primary Sjögren's syndromeR J Barry, N Sutcliffe, D A Isenberg, et al.The Journal of Clinical Investigation|October 21, 2014
BRAF inhibitor-associated ERK activation drives development of chronic lymphocytic leukemiaNiuscha Yaktapour, Frank Meiss, Justin Mastroianni, et al.Journal of Medicinal Chemistry|December 25, 2015
Novel Small Molecule Inhibitors of Choline Kinase Identified by Fragment-Based Drug DiscoveryStephan G Zech, Anna Kohlmann, Tianjun Zhou, et al.Pageof 22